K. Foweraker

The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes

M. Plumb, G. Giotopoulos, I. Peat, 2007, British Journal of Cancer.

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.

J. Chang-Claude, T. Vercauteren, A. Dunning, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hypoxia imaging with [18F]HX4 PET in squamous cell head and neck cancers: a pilot study for integration into treatment planning

A. Perkins, R. A. O’Connor, K. Foweraker, 2018, Nuclear medicine communications.

Metastatic spinal cord syndromes: imaging appearances and treatment planning.

C. I. Adams, K. Foweraker, A. O'connor, 2005, Clinical radiology.

Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort

D. Evans, D. Halliday, R. Jena, 2016, Journal of Neuro-Oncology.

High-dose radiotherapy in the management of chordoma and chondrosarcoma of the skull base and cervical spine: Part 1--Clinical outcomes.

R. Laing, R. Jena, N. Burnet, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres.

J. Lester, C. Comins, R. Pickles, 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

J. Chang-Claude, A. Dunning, R. Stock, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Factors associated with survival in small cell lung cancer: an analysis of real-world national audit, chemotherapy and radiotherapy data.

R. Hubbard, T. McKeever, D. Baldwin, 2021, Annals of palliative medicine.

Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression

D. Halliday, R. Jena, M. Kellett, 2023, Neuro-oncology advances.